Skip to content

Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney disease

Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney disease - Investigating the efficacy of community pharmacy intervention on serum potassium levels in patients with chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049814
Enrollment
40
Registered
2022-12-18
Start date
2022-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Nutrition counseling: Provide one nutritional guidance session at the time of visit to the office with written instructions on diet therapy.

Sponsors

National Hospital Organization Mie Chuo Medical Center
Lead Sponsor
Mie Pharmaceutical Association
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with estimated glomerular filtration rate less than 45 mL/min/1.73 m2 attending National Hospital Organization Mie Chuo Medical Center

Exclusion criteria

Exclusion criteria: 1) Patients who do not agree to participate in this study 2) Patients with communication difficulties 3) Patients with hypokalemia (serum potassium level less than 4.0 mmol/L) 4) Patients on maintenance dialysis 5) Patients who bring refill prescriptions 6) Patients taking oral potassium preparations 7) Patients who are not expected to continuously visit the insurance pharmacy under study for at least 3 months

Design outcomes

Primary

MeasureTime frame
The primary endpoints is the changes in serum potassium levels before and after the intervention.

Secondary

MeasureTime frame
The secondary endpoint is the change in patients' attitudes toward potassium restriction.

Countries

Japan

Contacts

Public ContactYuki Asai

National Hospital Organization Mie Chuo Medical Center Pharmacy

yuki0715asai@gmail.com059-259-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026